What is Tykerb
Approved as Treatment by the FDALapatinib, also called Tykerb, is approved by the FDA for 4 uses which include Advance Directives and Breast .
When to interrupt dosageThe prescribed measure of Tykerb is contingent upon the diagnosed ailment, including Advance Directives, Postmenopause and Metastatic Breast Cancer. The magnitude of dosage is contingent upon the technique of delivery (e.g. Tablet - Oral or Oral) outlined in the table beneath.
WarningsThere are 20 known major drug interactions with Tykerb.
Tykerb Novel Uses: Which Conditions Have a Clinical Trial Featuring Tykerb?78 active trials are being conducted to assess the potential of Tykerb in managing Advance Directives, Metastatic Breast Cancer and Breast Diseases.
Tykerb Reviews: What are patients saying about Tykerb?
Patient Q&A Section about tykerbThese questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How long can you take Tykerb?
"Tykerb can be taken indefinitely as part of a regimen including the chemotherapy medication Xeloda or the hormonal therapy medicine Femara, both of which are pills taken orally. This approach helps to keep the cancer under control."
When should I take Tykerb?
"The recommended dose of TYKERB is 5 tablets taken all at once, at least one hour before or one hour after a meal, once a day. Dividing the daily dose is not recommended. Capecitabine should be taken with food or within 30 minutes after food."
What is Tykerb used to treat?
"Lapatinib is used to treat a certain type of [breast cancer](https://www.withpower.com/clinical-trials/breast-cancer) that is positive for the HER2 protein. It works by slowing or stopping the growth of cancer cells."
Is Tykerb chemotherapy?
"Tykerb is a targeted chemotherapy drug that is taken with another drug to treat breast cancer. The drugs that it is taken with are Xeloda (capecitabine) or Femara (letrozole)."